Drugs Made In America Acquisition (DMIIU) Cash from Operations (2025 - 2026)
Drugs Made In America Acquisition (DMIIU) reported Cash from Operations of -$314,864 for Q4 2025.
Powered by 
Analysis
Drugs Made In America Acquisition (DMIIU) Cash from Operations (2025 - 2026) Analysis & Trends
For FY2025, Drugs Made In America Acquisition posted Cash from Operations of -$1.02 million.
- By year, Cash from Operations came in at -$194,299 in FY2024.
Peer Set
Peer Comparison
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -172,746.00 |
| Mar 31, 2026 | -102,503.00 |
| Dec 31, 2025 | -314,864.00 |
| Sep 30, 2025 | -690,726.00 |
API Access
Drugs Made In America Acquisition Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=DMIIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "DMIIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=DMIIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();